Citigroup’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Citigroup’s Portfolio DRTX Stock Details DRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-540	Closed	-$7K	–	7629
2014 Q3	$7K	Buy	540 +389	+258%	+$5.81K	﹤0.01%	6459
2014 Q2	$3K	Sell	151 -1,308	-90%	-$19.5K	﹤0.01%	6699
2014 Q1	$19K	Sell	1,459 -4,772	-77%	-$62.5K	﹤0.01%	6071
2013 Q4	$80K	Buy	6,231 +6,037	+3,112%	+$63.3K	﹤0.01%	5424
2013 Q3	$2K	Buy	194 +177	+1,041%	+$1.47K	﹤0.01%	6636
2013 Q2	$0	Buy	+17	New	+$125	﹤0.01%	6872

Citigroup's DRTX Position: Q4 2014 in Review

Citigroup sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2014, closing a stake of 540 shares — an estimated $7K sold.

Citigroup first reported a position in DRTX in Q2 2013 and held it in 6 quarters. The position peaked at $80K in Q4 2013. 0 funds tracked by Wall St. Rank hold DRTX as of Q4 2014.

Citigroup reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
Citigroup sold 540 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $7K.
Citigroup first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 6 quarters.
Citigroup's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $80K in Q4 2013.
0 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on Citigroup's 13F filing for Q4 2014, filed 17 Feb 2015.